Myopenia Predicts Poor Survival Outcomes After Radical Gastrectomy in Gastric Cancer Patients

Myopenia significantly reduces both overall and disease-free survival in gastric cancer patients post-radical gastrectomy. In a cohort of 943 patients, those with myopenia had a five-year overall survival rate of 45.5%, compared to 69.3% for those without. A new nomogram integrating myopenia risk assessments outperformed traditional staging systems, offering improved predictive accuracy for three- and five-year outcomes and allowing for better patient stratification.